Compare EVCM & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVCM | RXRX |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2021 | 2021 |
| Metric | EVCM | RXRX |
|---|---|---|
| Price | $10.12 | $3.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $10.67 | $7.50 |
| AVG Volume (30 Days) | 159.2K | ★ 22.2M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 145.45 | 14.79 |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $588,907,000.00 | $74,681,000.00 |
| Revenue This Year | $7.39 | $12.11 |
| Revenue Next Year | $5.84 | $82.52 |
| P/E Ratio | $254.25 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $7.66 | $2.77 |
| 52 Week High | $14.41 | $7.18 |
| Indicator | EVCM | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 52.21 |
| Support Level | $9.49 | $2.88 |
| Resistance Level | $12.40 | $4.01 |
| Average True Range (ATR) | 0.52 | 0.25 |
| MACD | 0.15 | 0.02 |
| Stochastic Oscillator | 65.83 | 48.00 |
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. The Company served more than 745,000 customers across three core verticals: EverPro for Home Services; EverHealth for Health Services; and EverWell for Wellness Services. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.